The Patent Finder

Acerus Pharmaceuticals Corporation

Also on record
Records under this name other than the patents Acerus Pharmaceuticals Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 5 of 5 · Back to Acerus Pharmaceuticals Corporation

PatentTitleStatus Expires Confidence
US 11,419,914Safe Desmopressin Administration
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,925,232Methods and Compositions Comprising Desmopressin in Combination with a 5-Alpha Reductase Inhibitor
Lapsed on the fee record
Ended Mar 27, 2026 · High confidence
Lapsed on the fee recordEnded Mar 27, 2026High confidence
US 7,799,761Pharmaceutical Compositions Including Low Dosages of Desmopressin
Term ended
Term ended Sep 26, 2024 · Medium confidence
Term endedTerm ended Sep 26, 2024Medium confidence
US 7,405,203Pharmaceutical Compositions Including Low Dosages of Desmopressin
Term ended
Term ended May 6, 2023 · Medium confidence
Term endedTerm ended May 6, 2023Medium confidence
US 8,143,225Pharmaceutical Compositions Including Low Dosages of Desmopressin
Term ended
Ended no later than May 6, 2023 · Low confidence
Term endedEnded no later than May 6, 2023Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited